• Je něco špatně v tomto záznamu ?

Determining a Short Form Montreal Cognitive Assessment (s-MoCA) Czech Version: Validity in Mild Cognitive Impairment Parkinson's Disease and Cross-Cultural Comparison

O. Bezdicek, M. Červenková, TM. Moore, H. Stepankova Georgi, Z. Sulc, DA. Wolk, DA. Weintraub, PJ. Moberg, R. Jech, M. Kopecek, DR. Roalf

. 2020 ; 27 (8) : 1960-1970. [pub] 20180621

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články, Research Support, N.I.H., Extramural, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc21026356

Grantová podpora
K01 MH102609 NIMH NIH HHS - United States
P30 AG010124 NIA NIH HHS - United States
P50 NS053488 NINDS NIH HHS - United States

The Montreal Cognitive Assessment (MoCA) is one of the most common screening instruments for mild cognitive impairment. However, the standard MoCA is approximately two times longer to administer than the Mini-Mental State Examination. A total of 699 Czech and 175 American participants received the standard MoCA Czech and English versions and in the clinical part, a sample of 102 nondemented patients with Parkinson's disease (PD). We created a validated Czech short version (s-MoCA-CZ) from the original using item response theory. As expected, s-MoCA-CZ scores were highly correlated with the standard version (Pearson r = .94, p < .001). s-MoCA-CZ also had 80% classification accuracy in the differentiation of PD mild cognitive impairment from PD without impairment. The s-MoCA-CZ, a brief screening tool, is shorter to administer than the standard MoCA. It provides high-classification accuracy for PD mild cognitive impairment and is equivalent to that of the standard MoCA-CZ.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc21026356
003      
CZ-PrNML
005      
20211026132950.0
007      
ta
008      
211013s2020 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1177/1073191118778896 $2 doi
035    __
$a (PubMed)29929376
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Bezdicek, Ondrej $u Department of Neurology, First Faculty of Medicine, Charles University, Prague, Czech Republic $u National Institute of Mental Health, Klecany, Czech Republic
245    10
$a Determining a Short Form Montreal Cognitive Assessment (s-MoCA) Czech Version: Validity in Mild Cognitive Impairment Parkinson's Disease and Cross-Cultural Comparison / $c O. Bezdicek, M. Červenková, TM. Moore, H. Stepankova Georgi, Z. Sulc, DA. Wolk, DA. Weintraub, PJ. Moberg, R. Jech, M. Kopecek, DR. Roalf
520    9_
$a The Montreal Cognitive Assessment (MoCA) is one of the most common screening instruments for mild cognitive impairment. However, the standard MoCA is approximately two times longer to administer than the Mini-Mental State Examination. A total of 699 Czech and 175 American participants received the standard MoCA Czech and English versions and in the clinical part, a sample of 102 nondemented patients with Parkinson's disease (PD). We created a validated Czech short version (s-MoCA-CZ) from the original using item response theory. As expected, s-MoCA-CZ scores were highly correlated with the standard version (Pearson r = .94, p < .001). s-MoCA-CZ also had 80% classification accuracy in the differentiation of PD mild cognitive impairment from PD without impairment. The s-MoCA-CZ, a brief screening tool, is shorter to administer than the standard MoCA. It provides high-classification accuracy for PD mild cognitive impairment and is equivalent to that of the standard MoCA-CZ.
650    _2
$a kognice $7 D003071
650    12
$a kognitivní dysfunkce $x diagnóza $7 D060825
650    _2
$a srovnání kultur $7 D003431
650    _2
$a lidé $7 D006801
650    _2
$a testy pro posouzení mentálních funkcí a demence $7 D000073216
650    _2
$a neuropsychologické testy $7 D009483
650    12
$a Parkinsonova nemoc $x diagnóza $7 D010300
651    _2
$a Česká republika $7 D018153
655    _2
$a časopisecké články $7 D016428
655    _2
$a Research Support, N.I.H., Extramural $7 D052061
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Červenková, Markéta $u Department of Neurology, First Faculty of Medicine, Charles University, Prague, Czech Republic $u National Institute of Mental Health, Klecany, Czech Republic
700    1_
$a Moore, Tyler M $u Department of Psychiatry, University of Pennsylvania School of Medicine, Philadelphia, PA
700    1_
$a Stepankova Georgi, Hana $u National Institute of Mental Health, Klecany, Czech Republic
700    1_
$a Sulc, Zdenek $u National Institute of Mental Health, Klecany, Czech Republic
700    1_
$a Wolk, David A $u Department of Psychiatry, University of Pennsylvania School of Medicine, Philadelphia, PA
700    1_
$a Weintraub, Daniel A $u Department of Psychiatry, University of Pennsylvania School of Medicine, Philadelphia, PA $u Department of Neurology, University of Pennsylvania School of Medicine, Philadelphia, PA $u Parkinson's Disease and Mental Illness Research, Education and Clinical Centers (PADRECC and MIRECC), Philadelphia Veterans Affairs Medical Center, Philadelphia, PA
700    1_
$a Moberg, Paul J $u Department of Psychiatry, University of Pennsylvania School of Medicine, Philadelphia, PA
700    1_
$a Jech, Robert $u Department of Neurology, First Faculty of Medicine, Charles University, Prague, Czech Republic
700    1_
$a Kopecek, Miloslav $u Department of Neurology, First Faculty of Medicine, Charles University, Prague, Czech Republic $u National Institute of Mental Health, Klecany, Czech Republic
700    1_
$a Roalf, David R $u Department of Psychiatry, University of Pennsylvania School of Medicine, Philadelphia, PA
773    0_
$w MED00188155 $t Assessment $x 1552-3489 $g Roč. 27, č. 8 (2020), s. 1960-1970
856    41
$u https://pubmed.ncbi.nlm.nih.gov/29929376 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20211013 $b ABA008
991    __
$a 20211026132956 $b ABA008
999    __
$a ok $b bmc $g 1715159 $s 1146863
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2020 $b 27 $c 8 $d 1960-1970 $e 20180621 $i 1552-3489 $m Assessment $n Assessment $x MED00188155
GRA    __
$a K01 MH102609 $p NIMH NIH HHS $2 United States
GRA    __
$a P30 AG010124 $p NIA NIH HHS $2 United States
GRA    __
$a P50 NS053488 $p NINDS NIH HHS $2 United States
LZP    __
$a Pubmed-20211013

Najít záznam

Citační ukazatele

Možnosti archivace